VON CAMELIDEN STAMMENDE ANTIGEN BINDENDE POLYPEPTIDE
European patent · EP2310413 · In force
Register entry
- Publication number
- EP2310413
- Application number
- EP09772912
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 2, 2009
- Published
- Apr 20, 2011
- Granted
- Mar 1, 2017
- Protection ends at the latest
- Jul 1, 2029
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C07K 16/00 (2006.01)C07K 16/24 (2006.01)
- Priority
- GB 0812120 02.07.2008US 77730 P 02.07.2008US 110161 P 31.10.2008
- PCT application
- PCT/IB2009/006329 02.07.2009
- PCT publication
- WO2010/001251 07.01.2010
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Aug 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2025 → 31.07.2026
Published in Swissreg on 01.08.2025
- Aug 1, 2024
Change
Published in Swissreg on 01.08.2024
- Aug 1, 2023
Change
Published in Swissreg on 01.08.2023
- Aug 3, 2022
Change
Published in Swissreg on 03.08.2022
- Sep 23, 2017
Transferred
- Owner
- arGEN-X N.V., Willemstraat 5, 4811 AH Breda, Netherlands → argenx BVBA, Industriepark 7, 9052 Zwijnaarde, Belgium
Published in Swissreg on 23.09.2017
- Mar 21, 2017
Agent entered
- Representative
- Kirker & Cie S.A., 122, rue de Genève, Case postale 90, 1226 Geneve-Thônex
Published in Swissreg on 21.03.2017
- Mar 1, 2017
Granted
Published in Swissreg on 01.03.2017
Parties
Inventor
B-9830 Saint Martens Latem, BE
NL-2806 RG Gouda, NL
NL-4436 NA Oudelande, NL
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.